The retention characteristics of supercritical fluid chromatography (SFC) were represented in a similar manner as the McReynolds method in GC; the differences (d I) between the retention indices for five standard solutes were used. The difference in retention behavior between GC and SFC was evaluated by the angle between two retention vectors. It was suggested that cyclic compounds behave a little differently from acyclic compounds in SFC.
A practical method for the characterization of the retention behavior in supercritical fluid chromatography (SFC) was proposed, based on the retention index. Taking easier comparison with gas chromatography (GC) into consideration, a set of six test compounds were chosen: napthalene, 1-pentadecanol, 2-pentadecanone, n-pentadecanonitrile, isoquinoline and cyclododecane. Dimethylsilicone and carbon dioxide were selected as the standard stationary phase and the standard mobile phase, respectively. Thus, the differences in retention indexes for the test compounds between the SFC conditions in question and the standard SFC conditions, i.e., the ∆I values, were used for the expression of the retention characteristics, similarly to use of the McReynolds constants in GC. The difference or similarity of retention behavior could be evaluated by the angle between two vectors having six elements, which corresponded to two SFC conditions. This method could detect the small difference in the retention behavior on a slightly polar stationary phase: 50% methyl, 50% phenylsilicone between GC and SFC. This difference was attributed to the different behavior of cyclic compounds from that of non-cyclic compounds.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.